MNPR Monopar Therapeutics

• $105K bought by 1 insider
• $344K sold by 1 insider outside a trading plan
• $4M sold by 5 insiders under 10b5-1 plans

1. Insider
   Trade
   Value
   Traded, filed
2. Christopher M Starr Director
   Planned sale
   $659K 8,400 shares at $78.50 62% of stake
   Traded Oct 1 Filed Oct 5
   ↗
3. Chandler Robinson CEO
   Planned sale
   $2.6M 29,056 shares at $88.00 23% of stake
   Traded Sep 24 Filed Sep 28
   ↗
4. Kim R Tsuchimoto Director
   Planned sale
   $456K 4,090 shares at $111.39 100% of stake
   Traded Aug 26 Filed Aug 28
   ↗
5. Raymond Anderson Director
   Planned sale
   $352K 3,142 shares at $111.98 37% of stake
   Traded Aug 25 Filed Aug 28
   ↗
6. Patrice Rioux Insider
   Planned sale
   $111 1 share at $111.26 <0.1% of stake
   Traded Aug 26 Filed Aug 27
   ↗
7. Quan Anh Vu CFO
   Buy
   $105K 1,500 shares at $69.95 New stake
   Traded Dec 26, 2025 Filed Dec 29, 2025
   ↗
8. Arthur J Klausner Director
   Sale
   $344K 5,121 shares at $67.15 37% of stake
   Traded Dec 18, 2025 Filed Dec 19, 2025
   ↗

Also filed in the last 12 months, not counted as buying or selling: 18 option exercises, 11 share withholdings for taxes, and 2 other transactions.